BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 12502352)

  • 21. Derivatives of oxoisoaporphine alkaloids: a novel class of selective acetylcholinesterase inhibitors.
    Tang H; Ning FX; Wei YB; Huang SL; Huang ZS; Chan AS; Gu LQ
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3765-8. PubMed ID: 17451950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Huang L; Luo Z; He F; Lu J; Li X
    Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors.
    Camps P; Formosa X; Muñoz-Torrero D; Petrignet J; Badia A; Clos MV
    J Med Chem; 2005 Mar; 48(6):1701-4. PubMed ID: 15771413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
    Huang L; Shi A; He F; Li X
    Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
    J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates.
    Fang L; Kraus B; Lehmann J; Heilmann J; Zhang Y; Decker M
    Bioorg Med Chem Lett; 2008 May; 18(9):2905-9. PubMed ID: 18406135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease.
    Bolognesi ML; Cavalli A; Valgimigli L; Bartolini M; Rosini M; Andrisano V; Recanatini M; Melchiorre C
    J Med Chem; 2007 Dec; 50(26):6446-9. PubMed ID: 18047264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: Binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge.
    Rydberg EH; Brumshtein B; Greenblatt HM; Wong DM; Shaya D; Williams LD; Carlier PR; Pang YP; Silman I; Sussman JL
    J Med Chem; 2006 Sep; 49(18):5491-500. PubMed ID: 16942022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bis(7)-tacrine derivatives as multitarget-directed ligands: Focus on anticholinesterase and antiamyloid activities.
    Bolognesi ML; Bartolini M; Mancini F; Chiriano G; Ceccarini L; Rosini M; Milelli A; Tumiatti V; Andrisano V; Melchiorre C
    ChemMedChem; 2010 Aug; 5(8):1215-20. PubMed ID: 20486153
    [No Abstract]   [Full Text] [Related]  

  • 30. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
    Loewenstein Y; Gnatt A; Neville LF; Soreq H
    J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonism.
    Lange JH; Coolen HK; van der Neut MA; Borst AJ; Stork B; Verveer PC; Kruse CG
    J Med Chem; 2010 Feb; 53(3):1338-46. PubMed ID: 20047331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.
    Carolan CG; Dillon GP; Gaynor JM; Reidy S; Ryder SA; Khan D; Marquez JF; Gilmer JF
    J Med Chem; 2008 Oct; 51(20):6400-9. PubMed ID: 18817366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase.
    Decker M
    J Med Chem; 2006 Sep; 49(18):5411-3. PubMed ID: 16942014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases.
    Alptüzün V; Prinz M; Hörr V; Scheiber J; Radacki K; Fallarero A; Vuorela P; Engels B; Braunschweig H; Erciyas E; Holzgrabe U
    Bioorg Med Chem; 2010 Mar; 18(5):2049-59. PubMed ID: 20149667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
    Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE.
    Alonso D; Dorronsoro I; Rubio L; Muñoz P; García-Palomero E; Del Monte M; Bidon-Chanal A; Orozco M; Luque FJ; Castro A; Medina M; Martínez A
    Bioorg Med Chem; 2005 Dec; 13(24):6588-97. PubMed ID: 16230018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-situ synthesis of a tacrine-triazole-based inhibitor of acetylcholinesterase: configurational selection imposed by steric interactions.
    Senapati S; Cheng Y; McCammon JA
    J Med Chem; 2006 Oct; 49(21):6222-30. PubMed ID: 17034128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational approach to discover multipotent anti-Alzheimer drugs.
    Rosini M; Andrisano V; Bartolini M; Bolognesi ML; Hrelia P; Minarini A; Tarozzi A; Melchiorre C
    J Med Chem; 2005 Jan; 48(2):360-3. PubMed ID: 15658850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors.
    Shen Q; Peng Q; Shao J; Liu X; Huang Z; Pu X; Ma L; Li YM; Chan AS; Gu L
    Eur J Med Chem; 2005 Dec; 40(12):1307-15. PubMed ID: 16182411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, biological activity, and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type.
    Kapková P; Stiefl N; Sürig U; Engels B; Baumann K; Holzgrabe U
    Arch Pharm (Weinheim); 2003 Nov; 336(11):523-40. PubMed ID: 14639745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.